Licensed compounding pharmacies can prepare customized formulations of medications based on a valid prescription for a specific patient
Its ability to mimic the incretin effect, enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, positions it as a valuable tool in the therapeutic arsenal against obesity and type 2 diabetes
Our portfolio is focused initially on three therapeutic areas with the potential to expand to additional therapeutic areas in the future: 3 Beyond our initial therapeutic areas of focus, we intend to evaluate opportunities in additional therapeutic areas where GPCRs are directly connected to disease pathology, including in areas of neurology, womens health, cardiovascular disease, and respiratory disease
The JPML found that the GLP-1 NAION lawsuits shared common questions of fact, including allegations that Plaintiffs use of certain GLP-1 RA drugs caused them to suffer from non-arteritic anterior ischemic optic neuropathy (NAION)